Mauldin, Frank William
- Rivanna Medical, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,225
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,225
By linked amount among FY2023 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Mauldin, Frank William as a PI. Multi-PI records show the full award amount for context.
- 1R44AR083337-01R44Contact PIDevelopment of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain$1Maward amount
- 5R44NS120798-03R44Contact PIReal-time three-dimensional spinal navigation system for bedside lumbar puncture placement$837.8Kaward amount
- 5SB1AR082178-02SB1Contact PICommercialization readiness for a 3D image guidance system to support interventional procedures in the spine and pelvis$342Kaward amount
Award organization
Organizations that administered FY2023 awards listing Mauldin, Frank William as a PI.
FY2023 award administered by Rivanna Medical, Inc. (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardRivanna Medical, Inc.
- 2014$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #8930
- 2016$2M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #4226
- 2021$5M Cumulative Funding
- 2023$10M Cumulative Funding